| Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer (NCT00288444) | Emory University | 2006-01-01 |
| Phase II Study of ZD6474 in Advanced NSCLC (NCT00290537) | M.D. Anderson Cancer Center | 2006-01-01 |
| Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region (NCT00693836) | Cancer Research Centre at Weston Park Hospital | 2006-01-01 |
| Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer (NCT00080938) | Eastern Cooperative Oncology Group | 2005-12-20 |
| Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00309972) | University College, London | 2005-12-01 |
| Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer (NCT00453167) | National Cancer Center, Korea | 2005-12-01 |
| Development of Tuberculosis Diagnostic Kit (NCT00311207) | Taichung Veterans General Hospital | 2005-12-01 |
| Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation (NCT00264420) | The Cleveland Clinic | 2005-12-01 |
| Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer (NCT00897650) | Vanderbilt-Ingram Cancer Center | 2005-12-01 |
| Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery (NCT00293332) | University of California, San Francisco | 2005-12-01 |
| AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer (NCT00343408) | NCIC Clinical Trials Group | 2005-11-29 |
| SRS Study in Patients With Non-Small Cell Lung Cancer (NCT00489008) | M.D. Anderson Cancer Center | 2005-11-21 |
| Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00245154) | NCIC Clinical Trials Group | 2005-11-03 |
| Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer (NCT00898924) | Alliance for Clinical Trials in Oncology | 2005-11-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00301808) | Barbara Ann Karmanos Cancer Institute | 2005-11-01 |
| Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer (NCT00103207) | Eastern Cooperative Oncology Group | 2005-10-13 |
| Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer (NCT00278148) | Nathan Pennell, MD, PhD | 2005-10-01 |
| First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker (NCT00455936) | National Cancer Center, Korea | 2005-10-01 |
| AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00324597) | Jonsson Comprehensive Cancer Center | 2005-10-01 |
| Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype (NCT00717353) | National University Hospital, Singapore | 2005-10-01 |
| S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT00450281) | SWOG Cancer Research Network | 2005-10-01 |
| DNA Analysis of Blood and Tissue from Patients with Lung Cancer (NCT00471978) | Massachusetts General Hospital | 2005-09-01 |
| Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00411047) | Massachusetts General Hospital | 2005-09-01 |
| Computed Tomography (CT) Guided Lung Biopsy: Core or Fine Needle Aspiration (NCT00188526) | University Health Network, Toronto | 2005-09-01 |
| Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer (NCT00527982) | M.D. Anderson Cancer Center | 2005-09-01 |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer (NCT00282022) | Vion Pharmaceuticals | 2005-09-01 |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00117962) | Alliance for Clinical Trials in Oncology | 2005-09-01 |
| Blood Collection From Individuals With Lung Disease for Genetic Studies (NCT00362739) | Weill Medical College of Cornell University | 2005-09-01 |
| Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00309998) | University of Rochester | 2005-09-01 |
| Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00128622) | H. Kim Lyerly | 2005-09-01 |
| Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 (NCT00218179) | University of Minnesota | 2005-09-01 |
| Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer (NCT00508144) | M.D. Anderson Cancer Center | 2005-09-01 |
| Evaluation of the Bio-Seal Biopsy Track Plug (NCT00527722) | M.D. Anderson Cancer Center | 2005-09-01 |
| Early Lung Cancer Detection in High Risk Individuals (NCT02837809) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2005-09-01 |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors (NCT00433407) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00305786) | University of Miami | 2005-08-01 |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00234052) | Northwestern University | 2005-07-28 |
| Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer (NCT00193453) | SCRI Development Innovations, LLC | 2005-07-01 |
| Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET (NCT00180154) | Technische Universität Dresden | 2005-07-01 |
| Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer (NCT00107172) | Alliance for Clinical Trials in Oncology | 2005-07-01 |
| Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473) | Ludwig Institute for Cancer Research | 2005-07-01 |
| Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00278187) | Jonsson Comprehensive Cancer Center | 2005-07-01 |
| Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00276588) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00293280) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| ZD6474(Vandetanib) + Alimta Combo Study (NCT00506051) | Genzyme, a Sanofi Company | 2005-07-01 |
| Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT00227539) | University of Washington | 2005-07-01 |
| Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) (NCT00128102) | Merck Sharp & Dohme LLC | 2005-06-30 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors (NCT00227617) | University of California, San Francisco | 2005-06-08 |
| Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT00248495) | Roswell Park Cancer Institute | 2005-06-08 |
| Sleep Disturbance in Lung Cancer Patients. (NCT00187980) | University Hospital, Angers | 2005-06-01 |
| Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT00253591) | Medical Research Council | 2005-06-01 |
| Acupuncture for Post-Thoracotomy Pain (NCT00142532) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer. (NCT00398970) | Haukeland University Hospital | 2005-06-01 |
| The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor (NCT00257179) | National Taiwan University Hospital | 2005-06-01 |
| Genetic Susceptibility to Lung Cancer in Never Smokers (NCT00597636) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer (NCT00111839) | EMD Serono | 2005-05-31 |
| Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer (NCT00280748) | UNC Lineberger Comprehensive Cancer Center | 2005-05-01 |
| Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases (NCT00238251) | Swiss Cancer Institute | 2005-05-01 |
| Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy (NCT01839032) | Pierre Fabre Medicament | 2005-05-01 |
| Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer (NCT00398385) | National Cancer Center, Korea | 2005-05-01 |
| Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer (NCT03515252) | Ivy Life Sciences, Co., Ltd | 2005-04-26 |
| Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer (NCT00113386) | Radiation Therapy Oncology Group | 2005-04-01 |
| Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00275132) | University College, London | 2005-04-01 |
| Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00387322) | University of California, Davis | 2005-03-01 |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00389805) | University of California, Davis | 2005-03-01 |
| Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers (NCT00188890) | University Health Network, Toronto | 2005-03-01 |
| Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer (NCT00083083) | American College of Radiology Imaging Network | 2005-03-01 |
| Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00112710) | University Hospital Birmingham | 2005-03-01 |
| Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer (NCT00098917) | Jonsson Comprehensive Cancer Center | 2005-02-01 |
| Aging and Cancer Effects (ACE) Study (NCT00204880) | University of Wisconsin, Madison | 2005-02-01 |
| EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer (NCT00119470) | University Hospital, Ghent | 2005-02-01 |
| Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Anatomic Lung Resection Versus Thoracotomy and Anatomic Lung Resection (NCT00598000) | Memorial Sloan Kettering Cancer Center | 2005-02-01 |
| AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) (NCT00107250) | NCIC Clinical Trials Group | 2005-01-21 |
| Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00094861) | Swedish Orphan Biovitrum | 2005-01-01 |
| Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis (NCT00166972) | National Taiwan University Hospital | 2005-01-01 |
| Iressa Follow-up Trial (NCT00357734) | AstraZeneca | 2005-01-01 |
| Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC (NCT00188617) | University Health Network, Toronto | 2005-01-01 |
| Broccoli Sprout Extract in Preventing Lung Cancer in Smokers (NCT00255775) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-01-01 |
| Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00094835) | Amgen | 2005-01-01 |
| Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit Smoking (NCT00341341) | National Human Genome Research Institute (NHGRI) | 2004-12-07 |
| A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making (NCT00122135) | VA Office of Research and Development | 2004-12-01 |
| A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients (NCT00201825) | Tony Bekaii-Saab | 2004-12-01 |
| Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer (NCT00101907) | Amgen | 2004-12-01 |
| 11C Topotecan PET Imaging (NCT00253461) | Case Comprehensive Cancer Center | 2004-12-01 |
| Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy (NCT00450567) | Jonsson Comprehensive Cancer Center | 2004-12-01 |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors (NCT00388089) | University of California, Davis | 2004-12-01 |
| Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer (NCT00103051) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-12-01 |
| Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura (NCT00601848) | Abramson Cancer Center at Penn Medicine | 2004-11-01 |
| Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00287989) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-11-01 |
| Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning (NCT00596310) | Susanne Arnold | 2004-11-01 |
| Respiratory Tumor and Normal Tissue Motion (NCT00415675) | M.D. Anderson Cancer Center | 2004-11-01 |
| Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00100854) | Translational Oncology Research International | 2004-10-28 |
| Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer (NCT00062062) | Alliance for Clinical Trials in Oncology | 2004-10-01 |
| Danish Lung Cancer Screening Trial (DLCST) (NCT00496977) | Danish Lung Cancer Group | 2004-10-01 |
| Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer (NCT00103116) | Edward Hirschowitz | 2004-10-01 |
| Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates (NCT00104728) | H. Lee Moffitt Cancer Center and Research Institute | 2004-10-01 |
| Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00098462) | Jonsson Comprehensive Cancer Center | 2004-10-01 |
| Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies (NCT00451022) | National Cancer Institute (NCI) | 2004-09-13 |
| Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer (NCT00735878) | Konstantin Dragnev | 2004-09-01 |